KKR has formed Gamma Biosciences, a new investment platform to acquire a portfolio of companies in the bioprocessing technology sector. KKR and its co-investors have committed $200 million of capital to Gamma, with KKR’s share coming from the firm’s Health Care Strategic Growth Fund, a $1.45 billion fund that was raised in 2017. Gamma has…...
